Gene · 51564
Papers2,197
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,197
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neurogenesis and the Epigenetic Landscape: Role of Histone Modifications and Chromatin Remodeling. | Brain Behav | 2026 | 41601423 | PubTator, text mining | PubMed |
| Oligodendrocyte transcription factor 2 orchestrates glioblastoma immune evasion by suppressing CXCL10 and CD8+ T cell activation. | J Clin Invest | 2026 | 41591814 | PubTator, text mining | PubMed |
| Histone and non-histone (de)acetylation impact on the blood-brain barrier. | Fluids Barriers CNS | 2026 | 41566325 | PubTator, text mining | PubMed |
| GRK5 Overexpression Drives Malignant Glioma Progression Through HDAC7 Alongside Canonical GPCR Signaling. | FASEB J | 2026 | 41553075 | PubTator, text mining | PubMed |
| Epigenetic Inhibition of HDAC7 by Daidzein isolated from Macrotyloma uniflorum: A potential therapeutic approach in leukemia in silico, in-vitro and in-vivo. | Med Oncol | 2026 | 41524858 | PubTator, text mining | PubMed |
| Crotonylation and the Risk of Head and Neck Cancer: Insights from a Two-Sample Mendelian Randomization Study. | Int Dent J | 2026 | 41447823 | PubTator, text mining | PubMed |
| Multifaceted roles of HDAC7 in disease and the evolving chemical toolkit for its modulation. | Bioorg Med Chem Lett | 2026 | 41421682 | PubTator, text mining | PubMed |
| Class IIa HDACs forced degradation allows resensitization of oxaliplatin-resistant FBXW7-mutated colorectal cancer. | Mol Oncol | 2026 | 41174352 | PubTator, text mining | PubMed |
| Characterization of molecular interactions between HDAC7 and MEF2A. | J Biomol Struct Dyn | 2026 | 39660765 | PubTator, text mining | PubMed |
| Identification of epigenetic monotherapy candidates in taxane-resistant CRPC. | Turk J Biol | 2025 | 41496857 | PubTator, text mining | PubMed |
| Thermal shift engagement assay for Class IIA histone deacetylase inhibitor screening. | Results Chem | 2025 | 41473577 | PubTator, text mining | PubMed |
| Histone deacetylase HDAC7 restricts CD8 + T cell tumor infiltration and limits immunotherapy sensitivity in bladder cancer: reversal by pinocembrin. | J Exp Clin Cancer Res | 2025 | 41444923 | PubTator, text mining | PubMed |
| Psychosomatic Disorders, Epigenome, and Gut Microbiota. | Cells | 2025 | 41439979 | PubTator, text mining | PubMed |
| Upregulated astrocytic HDAC7 induces depression-like disorders via deacetylating PINK1 and inhibiting mitophagy. | J Neuroinflammation | 2025 | 41286926 | PubTator, text mining | PubMed |
| Activation of the Piezo1 channel stimulates protein kinase D and migration in human aortic endothelial cells. | Am J Physiol Cell Physiol | 2025 | 41071645 | PubTator, text mining | PubMed |
| Harmine inhibits ovarian cancer migration and invasion and epithelial-mesenchymal transition (EMT) by inhibiting HDAC7 to restore RECK expression. | Biochem Pharmacol | 2025 | 41061932 | PubTator, text mining | PubMed |
| Novel selective indole based histone deacetylase 10 inhibitors as anticancer therapeutics. | Sci Rep | 2025 | 41006293 | PubTator, text mining | PubMed |
| Inhibition of HDAC7 reprograms the histone H3.3 landscape to induce heterochromatin spreading and DNA replication defects in cancer cells. | J Biol Chem | 2025 | 40967435 | PubTator, text mining | PubMed |
| Histone deacetylase 7 mediates lipopolysaccharide-inducible mitochondrial fission in macrophages. | J Cell Sci | 2025 | 40888031 | PubTator, text mining | PubMed |
| Partners in Silencing: Decoding the Mammalian Argonaute Interactome. | Noncoding RNA | 2025 | 40863728 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51564/papers?page=2